Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT00788255
In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.
Professor of Anesthesiology, Perioperative and Pain Medicine (OB)
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Inclusion Criteria:All obstetric patients with singleton pregnancies admitted to the labor
and delivery unit at Lucile Packard Childrens Hospital awaiting elective induction of labor
or elective Cesarean delivery. We will select 25 healthy ASA 1 patients with singleton
pregnancies who are scheduled for uncomplicated elective induction of labor. Gestational
age equal to or greater than 37 weeks.
Exclusion Criteria:Patients with underlying coagulation disorders. Patients with
thrombocytopenia. Patients with pregnancy-induced hypertension, pre-eclampsia. Patients
admitted for non-elective cesarean section. Patients in active labor. Patients requiring
the following medications prior to surgery: NSAIDS, aspirin, anticoagulants.
Patients with significant obstetric or medical disease. No patients <18 years of age will
be recruited.
drug: Final exogenous oxytocin concentration=22.5 μU/mL
drug: Final exogenous oxytocin concentration=30.1μU/mL
drug: Final exogenous oxytocin concentration=32.9μU/mL
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alexander Butwick